Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polycystic Kidney, Autosomal Dominant | 6 | 2025 | 266 | 2.140 |
Why?
|
| Polycystic Kidney Diseases | 3 | 2024 | 73 | 1.080 |
Why?
|
| TRPP Cation Channels | 6 | 2025 | 81 | 1.050 |
Why?
|
| Valosin Containing Protein | 1 | 2025 | 8 | 0.940 |
Why?
|
| Cilia | 2 | 2025 | 172 | 0.870 |
Why?
|
| Epithelial Sodium Channels | 4 | 2014 | 21 | 0.730 |
Why?
|
| Kidney | 3 | 2025 | 1475 | 0.580 |
Why?
|
| Serine Proteases | 1 | 2014 | 19 | 0.430 |
Why?
|
| Cysts | 2 | 2025 | 113 | 0.410 |
Why?
|
| Patch-Clamp Techniques | 1 | 2014 | 293 | 0.400 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 4407 | 0.240 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2025 | 1 | 0.240 |
Why?
|
| Unfolded Protein Response | 1 | 2025 | 60 | 0.230 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2025 | 111 | 0.220 |
Why?
|
| Gene Editing | 1 | 2025 | 86 | 0.220 |
Why?
|
| Central Serous Chorioretinopathy | 1 | 2024 | 4 | 0.210 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2024 | 77 | 0.200 |
Why?
|
| Choroid | 1 | 2024 | 78 | 0.200 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2022 | 10 | 0.200 |
Why?
|
| Animals | 11 | 2025 | 37579 | 0.190 |
Why?
|
| Receptors, Androgen | 1 | 2024 | 153 | 0.190 |
Why?
|
| Liver Diseases | 1 | 2025 | 301 | 0.190 |
Why?
|
| Mutation, Missense | 3 | 2025 | 340 | 0.180 |
Why?
|
| Mice | 6 | 2025 | 18057 | 0.180 |
Why?
|
| Xenopus laevis | 3 | 2014 | 104 | 0.160 |
Why?
|
| Mice, Knockout | 2 | 2025 | 3064 | 0.160 |
Why?
|
| Oocytes | 3 | 2014 | 176 | 0.150 |
Why?
|
| Apoptosis | 2 | 2025 | 2571 | 0.150 |
Why?
|
| Proteolysis | 3 | 2014 | 173 | 0.150 |
Why?
|
| Trypsin | 2 | 2014 | 76 | 0.130 |
Why?
|
| Phenotype | 1 | 2025 | 3172 | 0.130 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 1761 | 0.130 |
Why?
|
| Protein Subunits | 2 | 2014 | 228 | 0.120 |
Why?
|
| Chymotrypsin | 2 | 2012 | 23 | 0.120 |
Why?
|
| Drug Discovery | 1 | 2016 | 146 | 0.120 |
Why?
|
| Protein Folding | 1 | 2016 | 277 | 0.110 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2014 | 4 | 0.110 |
Why?
|
| Mutation | 3 | 2022 | 3999 | 0.110 |
Why?
|
| Biotin | 1 | 2014 | 26 | 0.110 |
Why?
|
| Pruritus | 1 | 2014 | 64 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2014 | 377 | 0.100 |
Why?
|
| Bile Acids and Salts | 1 | 2014 | 151 | 0.100 |
Why?
|
| Epithelial Sodium Channel Agonists | 1 | 2012 | 1 | 0.100 |
Why?
|
| Cathepsins | 1 | 2012 | 26 | 0.090 |
Why?
|
| Fibrinolysin | 1 | 2012 | 21 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 226 | 0.090 |
Why?
|
| Ion Channel Gating | 1 | 2012 | 92 | 0.090 |
Why?
|
| Cholestasis | 1 | 2014 | 209 | 0.090 |
Why?
|
| Humans | 10 | 2025 | 140898 | 0.090 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 153 | 0.050 |
Why?
|
| Genetic Therapy | 1 | 2025 | 315 | 0.050 |
Why?
|
| Xenopus | 2 | 2012 | 89 | 0.050 |
Why?
|
| EF Hand Motifs | 1 | 2020 | 2 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2024 | 498 | 0.040 |
Why?
|
| Adult | 1 | 2022 | 39134 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 2152 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 2917 | 0.040 |
Why?
|
| Transcriptome | 1 | 2024 | 1007 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2024 | 949 | 0.030 |
Why?
|
| DNA | 1 | 2024 | 1438 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2024 | 1325 | 0.030 |
Why?
|
| Liver | 1 | 2025 | 1815 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2024 | 2497 | 0.030 |
Why?
|
| Gastrin-Releasing Peptide | 1 | 2014 | 7 | 0.030 |
Why?
|
| Natriuretic Peptides | 1 | 2014 | 9 | 0.030 |
Why?
|
| TRPA1 Cation Channel | 1 | 2014 | 5 | 0.030 |
Why?
|
| Nociceptors | 1 | 2014 | 41 | 0.030 |
Why?
|
| Benzylamines | 1 | 2014 | 44 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2024 | 2604 | 0.030 |
Why?
|
| Azetidines | 1 | 2014 | 46 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2014 | 88 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 170 | 0.030 |
Why?
|
| Neurons, Afferent | 1 | 2014 | 101 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2014 | 129 | 0.030 |
Why?
|
| Epithelial Sodium Channel Blockers | 1 | 2012 | 2 | 0.020 |
Why?
|
| Amiloride | 1 | 2012 | 27 | 0.020 |
Why?
|
| Ion Transport | 1 | 2012 | 62 | 0.020 |
Why?
|
| Dipeptides | 1 | 2012 | 54 | 0.020 |
Why?
|
| Valine | 1 | 2012 | 77 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 225 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2012 | 126 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 737 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 858 | 0.020 |
Why?
|
| Sulfones | 1 | 2012 | 127 | 0.020 |
Why?
|
| Sodium | 1 | 2012 | 195 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 1315 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2012 | 720 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2014 | 1113 | 0.020 |
Why?
|
| Female | 1 | 2014 | 75540 | 0.020 |
Why?
|